Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.41.9416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies

Oncologist
Cancer ResearchMedicineOncology
2019English

Intravenous Immunoglobulin Therapy Use in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel in the Juliet Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma With Residual Extranodal Involvement

Korean Journal of Internal Medicine
Internal Medicine
2008English

Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy